PMMA bone cement viscosity in vertebroplasty.

Viscosity of PMMA Bone Cement in Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures: A Randomized Controlled Trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21242

Enrollment

Registered

2012-02-14

Start date

2011-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painful osteoporotic vertebral fractures

Interventions

Percutaneous vertebroplasty with either high or low viscosity PMMA bone cement.

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive patients with one or more osteoporotic vertebral compression fractures attending our clinic and considered suitable candidates for PVP will be asked to take participate in this study.

Exclusion criteria

Exclusion criteria: Refusal of participation.

Design outcomes

Primary

Measure	Time frame
Incidence of cement leakage.	—

Secondary

Measure	Time frame
1. Incidence and clinical relevance of pulmonary and cardiac cement emboli; 2. Incidence of new (adjacent) OVCFs during the first year after PVP; 3. Postoperative pain and health-related quality of Life.	—

Contacts

Public ContactM.J. Nieuwenhuijse

Leiden University Medical Center Orthopedic surgery P.O. box 9600

M.J.Nieuwenhuijse@lumc.nl+31 (0)71 5263795

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)